SINOMED(SH:688108) Sou Hu Cai Jing·2025-07-03 09:13Company Overview - Sino Medical's closing price on July 2 was 11.08 yuan, down 1.34%, with a rolling PE ratio of 750.79 times and a total market value of 4.61 billion yuan [1] - The company specializes in the research, production, and sales of high-end interventional medical devices, including biodegradable drug-coated coronary stent systems and various types of balloon dilatation catheters [1] Financial Performance - In the first quarter of 2025, the company achieved operating revenue of 101 million yuan, a year-on-year increase of 10.75%, and a net profit of 2.97 million yuan, a year-on-year increase of 277.50% [2] - The sales gross margin for the same period was 59.66% [2] Shareholder Information - As of March 31, 2025, the number of shareholders for Sino Medical was 11,044, an increase of 381 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Industry Comparison - The average PE ratio for the medical device industry is 51.29 times, with a median of 37.02 times, placing Sino Medical at the 121st position in the industry ranking [1] - The company's static PE ratio is 3077.74 times, and its price-to-book ratio is 5.30 [2]